A finished NUR-635 Topic 2 antimicrobial selection rationale example, with the agent, dose, route and duration each defended and the stopping point stated explicitly. Searches like "nur 635 topic 2 assignment example", "nur635 topic 2 sample" and "nur-635 topic 2 example" land here.
What a finished NUR-635 Topic 2 antimicrobial selection rationale looks like
The finished example reasons from the likely organism outward. The probable pathogens for this infection in this patient are named first, with local resistance considered where it is known, and the agent follows from that coverage rather than from familiarity. Spectrum is discussed as a cost: a broader agent buys certainty and pays in resistance and in collateral effect, and the example says which trade it is making. Dose is justified against the site of infection, since a drug reaching blood adequately may not reach bone or cerebrospinal fluid. Duration carries evidence, and the example names the day the course ends and what would extend it. De-escalation is planned in advance rather than left to chance.
How an NUR-635 Topic 2 example is structured
The example prescribes with the reasoning attached at every step. It opens with the infection, the likely organisms and the patient factors that alter the list. A second section selects the agent from that coverage requirement and states what it is chosen against, including what it deliberately does not cover. A third justifies the dose and interval against the site of infection and the patient's renal or hepatic function. A fourth sets the route, with a stated criterion for switching from intravenous to oral. A fifth commits to a duration with evidence and names the stopping date. A closing section plans de-escalation, saying what culture result would narrow the agent and who would review it, since a broad start with no review becomes a broad course.
Organisms named before the agent
Coverage requirements come from the likely pathogens, so the drug follows the reasoning rather than preceding it.
Spectrum treated as a cost
Breadth buys certainty and pays in resistance and collateral damage, and the paper says which trade it made.
Dose justified against the site
A concentration adequate in blood may not reach bone, joint or cerebrospinal fluid, which changes the dose.
A stopping date, not a range
The course ends on a stated day with evidence behind it, and the paper says what would extend it.
De-escalation planned in advance
What result would narrow the agent and who reviews it, since a broad start with no review becomes a broad course.
Where marks go in NUR-635 Topic 2
Prescriptions with no end date are the failure this topic addresses directly, and antimicrobial duration is the decision most often left open in student work. A second weakness is an agent chosen before the organisms are considered, which shows as a drug named in the first line with the coverage argument assembled afterward. Papers lose marks for reaching for broad coverage without acknowledging what it costs, since stewardship is part of the reasoning rather than a separate topic. Doses that ignore the site of infection produce technically correct prescriptions that would fail clinically. Omitting renal adjustment where the drug requires it is a safety error rather than an oversight. Agents chosen with no reference to local resistance patterns ignore the information most likely to matter.
Get an NUR-635 Topic 2 example written to your instructions
Send the NUR-635 Topic 2 instructions and the rubric from your classroom, with the infection and patient your section assigned. We write a custom example to those criteria, with likely organisms named first, spectrum treated as a cost, the dose justified against the site and a stopping date committed to, in 24 to 48 hours. The first is free.
NUR-635 Topic 2 questions, answered
How do I defend a duration rather than a range?
Pick a day and cite something. Many infections now have evidence supporting shorter courses than tradition uses, and naming the study or guideline behind your figure turns a habit into a decision. Then state what would extend it, such as a lack of clinical response by a defined point. A range with no commitment inside it is where most student prescriptions end, and it is what the topic is testing.
When is broad coverage justified?
When the patient is unstable, when the likely organisms genuinely span a wide range, or when missing coverage would be dangerous before cultures return. It is a legitimate choice with a stated cost. What makes it defensible is the plan attached: which result would narrow it, when that result is expected and who will act on it. Broad coverage without a de-escalation plan is the pattern stewardship programs exist to interrupt.
Why does the site of infection change the dose?
Because drugs distribute unevenly. An agent achieving adequate concentration in blood may reach very little into cerebrospinal fluid, bone, prostate or an abscess cavity, so the same infection in a different place needs a different dose or a different drug entirely. Stating the site and its penetration requirement is what separates a prescription that would work from one that is merely correct on paper.